Tempest Therapeutics, Inc.
Ticker: TPST
| Insider | Title |
|---|---|
| Christine A Pellizzari | Director |
| Geoffrey Nichol | Director |
| Justin Trojanowski | Corporate Controller |
| Michael Raab | Director |
| Nicholas Maestas | VP of Strategy and Finance |
| Pierre Lorenzo | Corporate Controller |
| Ronit Simantov | Director |
| Samuel Whiting | Chief Medical Officer |
| Side Fund Iv, L.p. Versant | 10% or greater ownership |
| Springs Capital Llc Rock | 10% or greater ownership |
| Springs Capital Management Lp Rock | 10% or greater ownership |
| Springs Capital Master Fund Lp Rock | 10% or greater ownership |
| Stella Xu | Director |
| Stephen R Brady | President and CEO, Director |
| Thomas W. Dubensky | President, Director |
| Thomas Woiwode | Director |
| Vantage Ii Gp, L.p. Versant | 10% or greater ownership |
| Vantage Ii Gp-gp, Llc Versant | 10% or greater ownership |
| Vantage Ii, L.p. Versant | 10% or greater ownership |
| Venture Capital Iv, L.p. Versant | 10% or greater ownership |
| Venture Capital Vi, L.p. Versant | 10% or greater ownership |
| Ventures Iv, Llc Versant | 10% or greater ownership |
| Ventures Vi Gp, L.p. Versant | 10% or greater ownership |
| Ventures Vi Gp-gp, Llc Versant | 10% or greater ownership |